Prakash Chand Negi

ORCID: 0000-0002-9613-6820
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Infective Endocarditis Diagnosis and Management
  • Streptococcal Infections and Treatments
  • Global Public Health Policies and Epidemiology
  • Health Promotion and Cardiovascular Prevention
  • Cardiovascular Disease and Adiposity
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Medicinal plant effects and applications
  • Fungal Biology and Applications
  • Cardiovascular Health and Disease Prevention
  • Lipoproteins and Cardiovascular Health
  • Surgical Sutures and Adhesives
  • Orthopedic Surgery and Rehabilitation
  • Cardiovascular Function and Risk Factors
  • Hematopoietic Stem Cell Transplantation
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Shoulder Injury and Treatment
  • Pulmonary Hypertension Research and Treatments
  • Sodium Intake and Health
  • Viral Infections and Immunology Research
  • Antimicrobial Resistance in Staphylococcus
  • Phytochemistry and Bioactivity Studies
  • Cancer, Lipids, and Metabolism
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Indira Gandhi Medical College
2017-2025

Defence Institute of Bio-Energy Research
2018

All India Institute of Medical Sciences Bhopal
2018

All India Institute of Medical Sciences Rishikesh
2018

NIMS University
2018

All India Institute of Medical Sciences Raipur
2018

All India Institute of Medical Sciences
2018

Dimple Kondal Panniyammakal Jeemon Sathyaprakash Manimunda Gitanjali Narayanan Anil J Purty and 88 more Prakash Chand Negi Sulaiman Ladhani Jyoti Sanghvi Kuldeep Singh Ajit Deshpande Nidhi Sobti Gurudayal Singh Toteja Dorairaj Prabhakaran Dorairaj Prabhakaran Sathyaprakash Manimunda Panniyammakal Jeemon Dimple Kondal Nidhi Sobti Kashvi Kahol Mumtaz Ali Gurudayal Singh Toteja Supriya Dwivedi Zian Gonmei Priyanka Bansal Jyoti Sanghvi Kuldeep Singh Ajit Deshpande Subodh Banzal Susmit Kosta Urvi Waghela Dinesh Dalal Late Narayan Suryawanshi Garima Singh Dleep Alawa Kamlesh Patidar Shankar Lal Maru Shailendra Singh Mandloi Varun Mandoliya Rahul Chouhan Laxman Singh Sulaiman Ladhani Harshada Anil Bhalerao Kranti Rayamane Maitreyee Patwardhan Himanshu Narendrabhai Bhatt Yogesh Ratilal Dave Nitaben Bharat Koriya Ramila Lakha Sondarava Rekhaben Vinod Thakar Sabnam Jariya Anjana Bhatt Asmita Subhashbhai Vadsariya A Kachi Reena Yadav M. Kariya Hansaben Patel Sanjay Patel Trupti Sachin Lalya Anil J Purty Prabhakaran Stalin Ramesh Chand Chauhan Zile Singh Yogesh Sharma Mark Christopher Maghida Sridhar Sangeeta Narayanasamy Prasanna Sundara Raju M. Sudha Radhika Devi S. Sivakami Sundari Vanitha Arulsamy Chinniah Devadas Allimuthu Nasudan Raja Rajeswaran Manglaraj Rajasekar Mohan Pammi Venkatesh Jeyalakshmi Sreenivasan Baby Rama Balakrishnan Bakkiyalakshmi Ranganatha Prakash Chand Negi Anjali Mahajan Rajeev Merwaha Virendra Mohan Singh Jaiswal Sucheta Sharma R. C. Dhiman Ravinder Kumar Reeta Sharma Ravindra Nath Thakur Ashu Kanwar Rama Kumari Pratibha Sharma Kiran Sharma Saurabh Thakur

Background Population-wide reduction in mean blood pressure is proposed as a key strategy for primary prevention of cardiovascular disease. We evaluated the effectiveness task-sharing involving frontline health workers elevated pressure. Methods and Results conducted DISHA (Diet lifestyle Interventions Hypertension Risk through Anganwadi Workers Accredited Social Health Activists) study, cluster randomized controlled trial 12 villages each from 4 states India. Frontline delivered custom-made...

10.1161/jaha.121.023526 article EN cc-by-nc-nd Journal of the American Heart Association 2022-03-01

Hypertension is often complicated by increased arterial stiffness and an independent predictor of adverse cardiovascular (CV) outcome. Beta blockers angiotensin receptor (ARBs) are commonly used antihypertensive agents. The effect beta ARBs on has not been compared adequately. aim the present study to compare telmisartan with metoprolol in hypertensive patients prospective open label randomized parallel group intervention study.100 hypertension, any agents, were enrolled after obtaining...

10.1016/j.ihj.2014.05.020 article EN publisher-specific-oa Indian Heart Journal 2014-06-16

Increased Left Ventricular Mass (LVM) is an independent risk factor for cardiovascular morbidity and mortality.This study was done to find the prevalence determinants of LVM in Northern Indian population.A prospective cross-sectional observational carried out a tertiary care centre Himachal Pradesh, India population included all consecutive patients fulfilling inclusion criteria attending cardiology OPD on seeking medical attention with various symptoms dyslipidaemia, hypertension but not...

10.7860/jcdr/2017/28048.10576 article EN cc-by-nc-nd JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH 2017-01-01

Background: Large body of data has demonstrated consistently that reduction in cardiovascular events with statins is a function level Low-Density Lipoprotein Cholesterol (LDL-C) both primary and secondary prevention trials irrespective baseline LDL-C Level. High dose are more effective than low reducing CV events. Doubling standard statin achieves only additional by 6%. Thus increasing rosuvastatin to 40 mg from 10 will reduce 12 percent only. Fenofibrate decrease 5-20%, thus the combination...

10.1254/jpssuppl.wcp2018.0_po1-2-74 article EN Proceedings for Annual Meeting of The Japanese Pharmacological Society 2018-01-01
Coming Soon ...